Owing to Briumvi's solid launch, TG's balance sheet is in excellent condition. Despite new competition, Briumvi's five-year ...

Swiss drugmaker Roche Holding plans to investigate whether an experimental medicine can delay or prevent Alzheimer’s disease ...

AbbVie, Bristol Myers Squibb and Eli Lilly appear “relatively well-positioned,” while Novartis and Roche look more at risk, ...

Pakistan Bait-ul-Maal has announced the toll out of key initiatives including NAI-ZINDGI drug rehabilitation center, Pakistan Cancer ...

Sarepta’s Elevidys is back on the market for ambulatory patients with Duchenne muscular dystrophy, Health Secretary Robert F. Kennedy Jr. reportedly plans to dissolve the U.S. Preventive Services Task ...

Venclexta has been on the market since 2016 for CLL, initially for 17p-mutated cases, and since 2019 has been used as a first ...

Indiana saw the second biggest small business growth in July, while President Trump is expected to impose tariffs on medicine ...

Whether you’re dealing with breakouts, uneven skin tone, or even signs of aging, azelaic acid might just be the missing ...

The enigma surrounding Hermès shares worth about €14 billion ($16.2 billion) inherited by a member of the luxury goods ...

University of Geneva researchers led a collaboration for testing different size-exclusion chromatography columns to compare ...

VFX houses Milk and Lola Post have been acquired by Phantom Digital Effects Limited, the parent company of VFX studios ...

The company is bullish about its prospects in the second half of the year, despite ongoing economic and geopolitical ...